Wolfe Research initiated coverage of Merck (MRK) with a Peer Perform rating. The firm said the main sentiment driver for Merck is ...

A European regulatory committee now recommends approval of the Alzheimer’s treatment lecanemab a few months after rejecting ...

For a fifth time this year, the FDA has scolded a pharma company for misleading marketing, this time over a Merz ...

The European Union's drugs regulator on Thursday said it recommends approval of Eisai and Biogen's Leqembi in patients with ...

As the rollout of its recently launched pulmonary arterial hypertension (PAH) drug Winrevair ramps up, Merck is continuing ...

What separates KL-50 from other chemotherapy drugs is its remarkable selectivity ... it was fundraising,” Lin told the News.

This adoption underscores TileDB’s foundational role in advancing precision medicine through drug discovery pipelines that are increasingly ... Prior to joining Alexion in 2015, George was employed by ...

German sci-tech giant Merck is very optimistic about its prospects in the Chinese market and will continue to strengthen its ...

“Since we haven’t made much progress in treating ... Catalyst® grant and was supported by Merck’s (known as MSD outside the ...

More recent acquisitions in 2024—oncology firms Mirati and RayzeBio and neurology firm Karuna—also help support Bristol's strong overall pipeline and wide moat. Bristol has created a strong pipeline ...

Phenylephrine is included in many cold and flu products, but a scientific panel last year found that it doesn't really do its ...

We recently compiled a list of the 10 Best Low Volatility Stocks to Invest in Now. In this article, we are going to take a ...